Similar articles

• Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.

  Wiedenmann B, Bäder HM, Scherubl H, Fett U, Zimmer T, Hamm B, Koppenhagen K, Riecken EO. Wiedenmann B, et al. Semin Oncol. 1994 Oct;21(5 Suppl 13):29-32. Semin Oncol. 1994. PMID: 7992077 No abstract available.
• Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.

  Pauwels S, Leners N, Fiasse R, Jamar F. Pauwels S, et al. Semin Oncol. 1994 Oct;21(5 Suppl 13):15-20. Semin Oncol. 1994. PMID: 7992075 No abstract available.
• [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].

  Banzo J, Abós MD, Prats E, García F, Razola P. Banzo J, et al. Rev Esp Med Nucl. 2000 Jun;19(3):225-41. Rev Esp Med Nucl. 2000. PMID: 11062088 Review. Spanish. No abstract available.
• [Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].

  Faiss S, Scherübl H, Bäder M, Fett U, Koppenhagen K, Wiedenmann B, Riecken EO. Faiss S, et al. Z Gastroenterol. 1994 May;32(5):243-6. Z Gastroenterol. 1994. PMID: 7915450 German.
• Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results.

  Krenning EP, Kwekkeboom DJ, Oei HY, de Jong RJ, Dop FJ, Reubi JC, Lamberts SW. Krenning EP, et al. Ann N Y Acad Sci. 1994 Sep 15;733:416-24. doi: 10.1111/j.1749-6632.1994.tb17291.x. Ann N Y Acad Sci. 1994. PMID: 7978890 Review. No abstract available.